Avitide, Inc., Secures Series A Financing To Commercialize Novel Biopharmaceutical Affinity Purification Technology

Avitide, Inc., a biotech company dedicated to the discovery and development of custom affinity purification solutions for the biopharmaceutical industry, announced the closing of their Series A financing. The Avitide technology is designed to discover and develop affinity purification products that will improve the fundamental timeframes and economics of commercial bioprocessing. The financing was led [...]

By | March 15th, 2013|Dartmouth Innovation, News|

Avedro Completes $43 Million Series D Financing

Avedro, Inc. announced today the completion of a $43 million Series D financing led by Abingworth along with a significant investment by Third Point. Avedro’s other investors include Prism Venture Works, De Novo Ventures, Flagship Ventures, Aperture Ventures, SCP Vitalife Venture Partners, Borealis Ventures and Echelon Ventures. As part of the transaction, David Mayer from [...]

By | March 5th, 2013|Dartmouth Innovation, News|